The stock price of Takeda Pharmaceutical Co ADR (NYSE: TAK) has plunged by -0.60 when compared to previous closing price of 13.36, but the company
Takeda Pharmaceutical Co ADR (NYSE: TAK) has a higher price-to-earnings ratio of 32.98x compared to its average ratio. TAK has 36-month beta value of 0.60.
Takeda Pharmaceutical Co ADR (NYSE: TAK) has a price-to-earnings ratio that is above its average at 33.46x. The stock has a 36-month beta value of
The stock price of Takeda Pharmaceutical Co ADR (NYSE: TAK) has surged by 0.38 when compared to previous closing price of 13.18, but the company
Takeda Pharmaceutical Co ADR (NYSE: TAK)’s stock price has plunge by 0.37relation to previous closing price of 13.62. Seeking Alpha reported 2024-03-25 that M&A activity
In the past week, TAK stock has gone down by -4.24%, with a monthly decline of -6.94% and a quarterly plunge of -5.05%. The volatility
© 2024, Powered by Smart TechOne
